Cancer
Conditions
Keywords
patient-reported outcomes (PRO), common terminology criteria for adverse events (CTCAE), quality of life, electronic data assessment
Brief summary
This open randomized trial investigates, if clinicians complete CTCAE ratings differently when receiving patients' patient-reported outcome (PRO) data prior to their CTCAE completion. The primary objective is to demonstrate superior inter-rater reliability of CTCAE ratings from physicians relying on EORTC PRO data as additional data source over traditional CTCAE ratings not including PRO information.
Detailed description
In oncology, detection and tracking of adverse events (AEs) are a top priority in both clinical trials and routine care. The classification of AEs mostly relies on the Common Toxicity Terminology for Adverse Events (CTCAE) developed by the US-American National Institutes of Health and the National Cancer Institute. It is known, however, that the assessment of AEs can greatly vary depending on whether they are assessed by patients or by clinicians. Procedure: The patients (any oncological diagnosis, day clinic or inpatient for treatment with chemotherapy or immunotherapy; open 1:1 randomized) fill out an EORTC quality of life questionnaire electronically (C30 + further questions). These PRO data are immediately available for the clinicians. Independently of each other, two different clinicians conduct a medical consultation with the patient and electronically a CTCAE rating. For the intervention Group, clinicians see the PRO values directly next to the input options for the CTCAE rating. For the control Group, clinicians see the input options for the CTCAE rating. The similarity of the assessments is checked using intra-class correlation. The combined use of PROs and CTCAE data makes particular sense for AEs/aspects that are directly experienced by the patient (fatigue, pain, cognitive problems, emotional functioning, ...) and can only be adequately recorded by the clinician through communication with the patient.
Interventions
Patient-reported outcomes are electronically assessed using EORTC QOL measures
CTCAE Ratings are conducted by clinicians
PRO data is displayed right next to the CTCAE rating
Sponsors
Study design
Eligibility
Inclusion criteria
* any Cancer diagnosis * current treatment with chemotherapy or immunotherapy * symptom burden equal or greater score 3 of the screening question On a scale of 0 to 10, to what degree did you experience physical or emotional symptoms/problems during the last week? * ability to understand the questions linguistically and cognitively * written informed consent Exclusion Criterion: * psychiatric diagnosis or mental health problems
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| EORTC Quality of Life Questionnaire C30 and additional questions from the EORTC Item Library | single assessment of quality of life before the medical consultation | patient-reported quality of life |
| CTCAE V5.0 | single assessment during the medical consultation with physician 1 on the same day of PRO assessment | physician 1 rates patient symptoms (17 CTCAE domains matching the EORTC C30 and additional questions) |
Countries
Austria